	CCR5
Psoriasis
Chemokine inhibitor
	CCR 5 CD
CCR 5 positive cells
non-lesional skin
expression
cells
psoriasis patients
immunohistochemical
CCR
significant
CD 3 cells
placebo
chronic plaque psoriasis
skin
CD 68
clinical
patients
PASI 50 responders
treatment
Positive
analysis
baseline
placebo group
randomized
antiCD
psoriasis
SCH 351125 group
single-stained sections
lesional
receptors
pathogenesis
PASI
double stained
Data
due
total number
days
results
number

